Cutting-edge research is advancing protein and RNA-based therapeutics. Raina Biosciences unveiled GEMORNA, a generative AI platform that designs mRNA sequences with enhanced stability and translational efficiency, demonstrated by up to 41-fold increased protein expression. Related studies explore microproteins critical for mitochondrial metabolism and the regulation of RNA-protein interactions, illuminating novel pathways for disease treatment across metabolic and cancer domains.